comparemela.com
  1. Home
  2. Live Updates
  3. Global Rare - Breaking News

Latest Breaking News On - Global rare - Page 4 : comparemela.com

Chiesi Global Rare Diseases Presents Long-Term Results from Phase 3 BALANCE and BRIGHT Studies in Fabry Disease at the 19th Annual WORLDSymposium™ Research Meeting

Chiesi Global Rare Diseases Presents Long-Term Results from Phase 3 BALANCE and BRIGHT Studies in Fabry Disease at the 19th Annual WORLDSymposium™ Research Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenUnited kingdomUnited statesInternational centerChiesi groupchiesiNicole muscholFabry diseasefabryNathalie guffonGiacomo chiesiResearch meetingB corpPreference centreUs food drug administrationChiesi groupUniversity medical center hamburgGlobal rare diseases

Chiesi Global Rare Diseases Presents Long-Term Results from Phase 3 BALANCE and BRIGHT Studies in Fabry Disease at the 19th Annual WORLDSymposium™ Research Meeting

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living.

Nordrhein westfalenUnited kingdomUnited statesInternational centerAdam daleyNicole muscholNathalie guffonGiacomo chiesiResearch meetingB corpPreference centreBerry company public relationsChiesi groupUniversity medical center hamburgGlobal rare diseasesChiesi global rare diseases

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomChiesi groupchiesiChiesi farmaceuticiGiacomo chiesiB corpGroup chiesiInternational society for mannosidosis related disordersDrug administrationMedia contactjenna urbanberry company public relationsChiesi groupEuropean commission for lamzedeGlobal rare diseasesChiesi global rareEuropean commissionMark stark

Lamzede Approved for Noncentral Nervous System Manifestations of Alpha-Mannosidosis

The FDA has approved Lamzede (velmanase alfa-tycv) for the treatment of non-CNS manifestations of alpha-mannosidosis in adult and pediatric patients.

Drug administrationBoxed warningGlobal rare diseasesGlobal rare

Chiesi Global Rare Diseases to Present at the 19th Annual WORLDSymposium™ Research Meeting

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living.

United kingdomNordrhein westfalenUnited statesInternational centerRobert hopkinJohn bernatBarbara burtonDerralynn hughesLisa berryNathalie guffonEric wallaceAdam daleyNicole muscholAlpha mannosidosisMaria joFlorian lagler

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.